Injection of botulinum toxin type A into the external urethral sphincter for male patients suffering from chronic prostatitis/chronic pelvic pain syndrome (NIH [National Institute of Health category III]): a prospective, double-blind and placebo-controlled clinical trial
Phase of Trial: Phase III
Latest Information Update: 31 Jan 2014
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Prostatitis
- Focus Therapeutic Use
- 31 Jan 2014 According to ClinicalTrials.gov record trial status changed to discontinued.
- 20 Aug 2010 Planned end date changed from 1 Apr 2010 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 20 Aug 2010 Additional lead trial investigator (Patrick Markart) identified as reported by ClinicalTrials.gov.